Home Health Products NantHealth® Showcases Connected Care Products at HIMSS & Health 2.0 European Conference 2019 – Business Wire

NantHealth® Showcases Connected Care Products at HIMSS & Health 2.0 European Conference 2019 – Business Wire

5 min read
0
14

HELSINKI & CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth,
Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized
health care company, showcases DeviceConX™,
HBox®
and VitalsConX,
leading solutions within their Connected Care product line, at HIMSS &
Health 2.0 European Conference 2019, taking place from June 11-13,
promising to be the most influential digital health conference in
Europe. The company will specifically discuss the power of collaborative
efforts with customers and partners to reduce clinician burden by
streamlining workflows to bring interoperability for providers.
NantHealth will be presenting at booth 6g10c at the first U.S. Pavilion,
hosted by HIMSS and the U.S. Commercial Service, further expanding the
reach of their leading health care technology solutions into the
European Union. NantHealth’s Connected Care platforms integrate medical
device data into clinical records, which may lead to a reduced length of
hospital stay, less costly medical errors, greater provider satisfaction
and improved care.

An extremely flexible software-based platform designed for complete
connectivity and interoperability, DeviceConX facilitates the capture of
patient data from any capable medical device. Leveraging a combination
of existing hardware investments—including bedside PCs, laptops,
tablets, workstations-on-wheels and NantHealth’s HBox
hardware—DeviceConX can then deliver that medical device data to an EMR
or any other clinical system quickly and accurately. HBox is a
hospital-grade PC appliance that acts as a hub to capture and relay
medical device data from hospital, ambulatory or home settings.
VitalsConX is a tablet-based tool that accelerates patient intake vitals
workflows and low acuity vital sign collection that accelerates rounding
assessment workflows by streamlining data validation and providing an
easy-to-use touch-based interface to collect custom parameters at the
point of care.

NantHealth plans to unveil VitalsConX 3.0 in August, sharing initial
information for the first time in Helsinki this week, and furthering
their mission of optimizing patient outcomes and enabling value-based
care through advancements in technology and precision medicine.

“It is vastly important for the digital disruption to become a reality
in the health care industry,” says Wes Madden, BSN, RN, Vice President
of Connected Care, NantHealth. “We are excited to be working
collaboratively with our partners to help bring health care into the
digital age by providing our European customers with greater
interoperability to increase clinician productivity and satisfaction,
while improving patient care.”

About NantHealth

NantHealth, a member of the NantWorks ecosystem of companies, provides
leading solutions across the continuum of care for physicians, payers,
patients and biopharmaceutical organizations. NantHealth enables the use
of cutting edge data and technology towards the goal of empowering
clinical decision support and improving patient outcomes. NantHealth’s
comprehensive product portfolio combines the latest technology in
molecular analysis (GPS Cancer® and Liquid GPS®),
payer/provider platforms that exchange information in near-real time
(NaviNet and Eviti), and connected care solutions that deliver Medical
Device Interoperability (MDI). NantHealth’s GPS Cancer®
molecular profiling provides comprehensive DNA & RNA tumor-normal
profiling combined with pharmacogenomics analysis. Liquid GPS®
provides non-invasive testing of cfDNA and cfRNA to monitor cancer
mutations and potentially select targeted therapies, chemotherapies, and
immunotherapies. For more information, please visit www.nanthealth.com
and follow us on Twitter,
Facebook
and LinkedIn.

Let’s block ads! (Why?)


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Valsartan: Another cancer-causing chemical found in widely used blood-pressure medication – CBS News

Online pharmacy Valisure has discovered another cancer-causing chemical in blood-pressure …